Innate Pharma S.A. (IPHA)
NASDAQ: IPHA · Real-Time Price · USD
2.100
+0.060 (2.94%)
May 14, 2025, 1:30 PM - Market open

Revenue by Product

Fiscal year is January - December.
Year Ending
Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 NaN - NaN
Research and Development of Pharmaceutical Products
61.64M
Log In
Log In
Log In
Log In
Upgrade
Research and Development of Pharmaceutical Products Growth
6.88%
Log In
Log In
Log In
Log In
Upgrade

Revenue by Geography

Fiscal year is January - December.
Year Ending
Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 NaN - NaN
France
61.64M
Log In
Log In
Log In
Log In
Upgrade
France Growth
6.88%
Log In
Log In
Log In
Log In
Upgrade